메로페넴 삼수화물

Meropenem is a semi-synthetic broad-spectrum antibiotic of the carbapenem class. It is active against Gram-positive and certain Gram-negative bacteria.

In Belgium, it was developed by Janssen Pharmaceutica and is sold by Merck Sharp & Dohme (MSD) in the US, Canada, 서유럽, Latin America, Australia, and New Zealand under the trade name Merrem.

It is a bactericidal drug belonging to the carbapenems group (a new generation of broad-spectrum beta-lactam antibiotics). Carbapenems are the most advanced class of antibiotics and are used to treat hospital-acquired bacterial infections.

They can defeat bacteria that have become resistant to other antibiotics. It appears as a white or slightly yellow powder.

Meropenem is a broad-spectrum antibiotic active against a wide variety of bacteria and is used to treat various types of bacterial infections.

It is mainly used to treat pneumonia and other conditions like bone and skin infections and infections after surgeries.

It works by stopping the growth of bacteria. It is also used to treat infant and child infections caused by gram-positive and gram-negative bacteria. It is often used to treat people who have infections that do not respond to other antibiotics.

It is also used to treat people who have conditions that are likely to become resistant to other antibiotics.